Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Corp
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company's principal business activity is the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL...
-2 with superior CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program Targeted Metalloprotease Activated SuperKine (T-MASK) programs are designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
(217)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Apr 04, 2024 9:36am
RE:RE:Pre Market
I apologize for jumping the gun. Not sure what was happening with the pre market quotes I was getting. Phhheeewwww!!!!
(217)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Apr 04, 2024 8:49am
RE:Pre Market
I'm assuming there's some bad news out there. Stocktwits has some info posted on testing results. Above my head, but I guess people aren't impressed. #%|!!
(217)
•••
13X2413
X
View Profile
View Bullboard History
Post by
13X2413
on Apr 04, 2024 8:18am
Pre Market
Is this some kind of error?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 04, 2024 7:00am
New Press Release - Medicenna to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced that Dr. Fahar Merchant, President and CEO of Medicenna...
read article.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Mar 31, 2024 7:13pm
Viking Therapeutics VKTX working on a novel
weight loss drug has risen from 8.28 to a high of 99.00 and has a current market cap of 9 billion .Medicinna has a MC of 130 million or about 69 times less than Viking .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Mar 30, 2024 9:41pm
RE:Interesting jump today?
Ask Merck .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Mar 29, 2024 2:52pm
RE:Interesting jump today?
I thought it was super interesting at 44 cents .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Mar 28, 2024 4:11pm
RE:Interesting jump today?
Insiders maybe , tight share structure , possible suitors , risk reward ratio is becoming obvious and the upcoming Poster presentation on current trials , very undervalued drugs they have
...more
(84)
•••
Brianw21
X
View Profile
View Bullboard History
Post by
Brianw21
on Mar 28, 2024 11:52am
Interesting jump today?
Topped at $2.10. The stock is becomnig interesting but does anyone know why today?
(99)
•••
windymayor1
X
View Profile
View Bullboard History
Comment by
windymayor1
on Mar 20, 2024 4:08pm
RE:Multiple news releases possible for this company eh .
Small cap takeovers continue in this sector as well. Fusion Pharma, a Phase 2 trial co. bought out by Astra Zen.for $2.3B yesterday!
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Mar 20, 2024 3:46pm
Multiple news releases possible for this company eh .
.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Mar 18, 2024 3:48pm
RE:RE:Out with the weak eh .
I bought this all the way from 1.35 down to .24 when they left Nasdaq which was a good move over a roll back . Made for some cheap stock . If they can outdo Keytruda than blue sky .eh .40 us and
...more
(84)
•••
Brianw21
X
View Profile
View Bullboard History
Comment by
Brianw21
on Mar 18, 2024 3:27pm
RE:Out with the weak eh .
I have a fair amount of this stock. They needed to get rid of the CEO which they did. Clinical trials seem to be going well. Any thoughts on how close we might be to some real market
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 06, 2024 7:00am
New Press Release - Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional Superkine, MDNA113, will also be presented at the Annual Meeting TORONTO and HOUSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a...
read article.
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Mar 05, 2024 9:49am
A positive update and this rockets , look at Viking
12$ to 99$ on positive weight loss drug .My target is 40 $ US .
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income